Provided by Tiger Trade Technology Pte. Ltd.

Vericel

42.30
-0.3800-0.89%
Post-market: 42.300.00000.00%19:30 EDT
Volume:812.27K
Turnover:34.53M
Market Cap:2.17B
PE:90.18
High:43.34
Open:42.68
Low:41.95
Close:42.68
52wk High:49.32
52wk Low:28.95
Shares:51.21M
Float Shares:50.46M
Volume Ratio:1.52
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4691
EPS(LYR):0.3200
ROE:7.16%
ROA:2.43%
PB:5.85
PE(LYR):132.19

Loading ...

Company Profile

Company Name:
Vericel
Exchange:
NASDAQ
Establishment Date:
1989
Employees:
398
Office Location:
25 Blue Sky Drive,Burlington,Massachusetts,United States
Zip Code:
01803
Fax:
617 588 5554
Introduction:
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Directors

Name
Position
Dominick Colangelo
Chief Executive Officer and Director and President
Robert L. Zerbe
Chairman of the Board
Alan Rubino
Independent Director
Heidi Hagen
Independent Director
Kevin McLaughlin
Independent Director
Lisa Wright
Independent Director
Paul Wotton
Independent Director

Shareholders

Name
Position
Dominick Colangelo
Chief Executive Officer and Director and President
Michael Halpin
Chief Operating Officer
Joe Mara
Chief Financial Officer
Jonathan Hopper
Chief Medical Officer
Sean Flynn
Chief Legal Officer